Cargando…
Mesenchymal stem cell carriers enhance anti-tumor efficacy of oncolytic virotherapy
Oncolytic viruses (OVs) specifically infect, replicate and eventually destroy tumor cells, with no concomitant toxicity to adjacent normal cells. Furthermore, OVs can regulate tumor microenvironments and stimulate anti-tumor immune responses. Mesenchymal stem cells (MSCs) have inherent tumor tropism...
Autores principales: | Wang, Xianyao, Zhao, Xing, He, Zhixu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882891/ https://www.ncbi.nlm.nih.gov/pubmed/33664802 http://dx.doi.org/10.3892/ol.2021.12499 |
Ejemplares similares
-
Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
por: Mahasa, Khaphetsi Joseph, et al.
Publicado: (2020) -
Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy
por: Reale, Alberto, et al.
Publicado: (2021) -
Oncolytic Virotherapy in Glioma Tumors
por: Rius-Rocabert, Sergio, et al.
Publicado: (2020) -
ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012) -
Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions
por: Kim, Janice, et al.
Publicado: (2015)